UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Catalogue
Articles
RSS feedX
Search Filters
Format
Subjects
Language
Publication DateJournal of hepatology, ISSN 0168-8278, 2012, Volume 58, Issue 1, pp. 155 - 168
Gastroenterology and Hepatology | Gallstones | Liver cancer | Bile acids | Fatty liver disease | Cholestasis | Liver regeneration | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Animals | Carrier Proteins - metabolism | Cholestasis - metabolism | Membrane Glycoproteins - metabolism | Humans | Liver - metabolism | Bile Acids and Salts - metabolism | Liver Diseases - metabolism | Liver Regeneration - physiology | Receptors, Cytoplasmic and Nuclear - metabolism | Drug resistance in microorganisms | Corticosteroids | Glucagon | Calcifediol | Ursodiol | Deoxycholic acid | Epidermal growth factor | Vitamin D | Physiological aspects | Fibroblast growth factors | Alfacalcidol | Index Medicus | IBABP (FABP6, ILBP), intestinal bile acid-binding protein, fatty acid-binding protein 6 | PFIC, progressive familial intrahepatic cholestasis | TNFα, tumor necrosis factor α | 3 (human) | SRC2, p160 steroid receptor coactivator | NAFLD, non-alcoholic fatty liver disease | BA, bile acid | bile acid receptor | 8, cholesterol efflux pump, ATP-binding cassette, subfamily G, member 5 | UDCA, ursodeoxycholic acid | LRH-1 (NR5A2), liver receptor homolog-1 | LCA, lithocholic acid | LXRα (NR1H3), liver X receptor alpha | PPARγ (NR1C3), peroxisome proliferator-activated receptor gamma | OSTαβ, organic solute transporter alpha | ABCG5 | AMPK, AMP activated protein kinase | NASH, non-alcoholic steatohepatitis | SHP (NR0B2), short heterodimer partner | OATP1A2 (SLCO1A2, OATP1, OATP-A, SLC21A3), solute carrier organic anion transporter family, member 1A2 | EGFR, epidermal growth factor receptor | IL6, interleukin 6 | TGR5, G protein-coupled bile acid receptor | PH, partial hepatectomy | AE2, anion exchanger 2 | PSC, primary sclerosing cholangitis | OATP1B1 (SLCO1B1, OATP2, OATP-C, SLC21A6), solute carrier organic anion transporter family, member 1B1 | RARα (NR1B1), retinoic acid receptor alpha | GLP-1, glucagon like peptide 1 | VDR (NR1I1), vitamin D receptor. Please note that for the convenience of better readability and clarity, abbreviations for transporters and nuclear receptors were capitalized throughout this article when symbols were identical for human and rodents | MRP2 (ABCC2), multidrug resistance-associated protein 2, ATP-binding cassette, subfamily C, member 2 | NTCP (SLC10A1), sodium | CAR (NR1I3), constitutive androstane receptor | taurocholate cotransporting polypeptide, solute carrier family 10, member 1 | PPARα (NR1C1), peroxisome proliferator-activated receptor alpha | Review | GR (NR3C1), glucocorticoid receptor | Bile acids, Cholestasis, Fatty liver disease, Gallstones, Liver regeneration, Liver cancer | 19, fibroblast growth factor 15 | Mdr2 | ICP, intrahepatic cholestasis of pregnancy | BRIC, benign recurrent intrahepatic cholestasis | OATP1B3 (SLCO1B3, OATP8, SLC21A8), solute carrier organic anion transporter family, member 1B3 | MRP3 (ABCC3), multidrug resistance-associated protein 3, ATP-binding cassette, subfamily C, member 3 | beta | MDR1 (ABCB1), p-glycoprotein, ATP-binding cassette, subfamily B, member 1 | norUDCA, norursodeoxycholic acid | 6-ECDCA, 6-ethylchenodeoxycholic acid | FXR (NR1H4), farnesoid X receptor | BCRP (ABCG2), breast cancer resistance protein, ATP-binding cassette, subfamily G, member 2 | HNF4α (NR2A1), hepatocyte nuclear factor 4 alpha | PBC, primary biliary cirrhosis | MDR3 (ABCB4), multidrug resistance protein 2 (rodents) | HNF1α, hepatocyte nuclear factor 1 alpha | NR, nuclear receptor | FGF15 | RXRα (NR2B1), retinoid X receptor alpha | PXR (NR1I2), pregnane X receptor | BSEP (ABCB11), bile salt export pump | HCC, hepatocellular carcinoma | MRP4 (ABCC4), multidrug resistance-associated protein 4, ATP-binding cassette, subfamily C, member 4 | TPN, total parenteral nutrition
Journal Article
Details 
Digital rights
Loading RightsJournal of hepatology, ISSN 0168-8278, 2015, Volume 64, Issue 3, pp. 674 - 681
Gastroenterology and Hepatology | Sclerosing | Sodium-dependent BA transporter (ASBT/SLC10A2) | Liver and bile duct injury | Cholangitis | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Cholangitis, Sclerosing - drug therapy | Liver - pathology | Bile Ducts - drug effects | Cholestasis - metabolism | Gallbladder - drug effects | Organic Anion Transporters, Sodium-Dependent - antagonists & inhibitors | Bile Ducts - injuries | Bile Acids and Salts - metabolism | Intestinal Absorption | Animals | Liver - drug effects | Symporters - antagonists & inhibitors | Mice | Cholestasis - drug therapy | Bile Ducts - pathology | Liver | Deoxycholic acid | Index Medicus | knockout mice | Gastroenterologi | glucagon-like peptide-1 | diarrhea | hco3-umbrella | ursodeoxycholic acid | biliary | farnesoid x receptor | circulation | nuclear receptor | epithelia | enterohepatic | unifying hypothesis
Journal Article
Details
Digital rights
Loading RightsExperimental biology and medicine (Maywood, N.J.), ISSN 1535-3702, 11/2014, Volume 239, Issue 11, pp. 1489 - 1504
G-protein-coupled BA receptor 1 (TGR5) | farnesoid X receptor | gastrointestinal carcinogenesis | polymorphism | apical sodium dependent bile acid transporter | metabolic syndrome | intestinal microbiota | Gut–liver axis | bile acids | inflammation | bacterial translocation | diabetes | gut dysbiosis | obesity | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Inflammation - complications | Gastrointestinal Neoplasms - epidemiology | Oxidative Stress | Humans | Bile Acids and Salts - metabolism | DNA Damage | Dysbiosis - complications | Gastrointestinal Tract - pathology | Gastrointestinal Neoplasms - etiology | Index Medicus
Journal Article
Details
Digital rights
Loading RightsJHEP Reports, ISSN 2589-5559, 04/2021, Volume 3, Issue 2, pp. 100222 - 100222
Journal Article
Details
Digital rights
Loading RightsJHEP Reports, ISSN 2589-5559, 04/2021, Volume 3, Issue 2, pp. 100214 - 100214
Journal Article
Details
Digital rights
Loading Rights
6.
Full Text
Bile acid regulation: A novel therapeutic strategy in non-alcoholic fatty liver disease
Pharmacology & therapeutics (Oxford), ISSN 0163-7258, 10/2018, Volume 190, pp. 81 - 90
Inflammation | Bile acids | Lipid metabolism | Non-alcoholic fatty liver disease | BA-activated receptor | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Animals | Drug Development - methods | Humans | Bile Acids and Salts - metabolism | Non-alcoholic Fatty Liver Disease - physiopathology | Disease Progression | Lipid Metabolism - physiology | Non-alcoholic Fatty Liver Disease - drug therapy | Immunoglobulin M | Phosphates | Drug resistance in microorganisms | Immunoglobulin G | Low density lipoproteins | Lipids | Medicine, Chinese | Bilirubin | T cells | S-adenosylmethionine | Immunity | Proteins | Fatty liver | Synthesis | Vitamin D | Blood cholesterol | Interleukins | Ligases | Sphingosine | Physiological aspects | Alfacalcidol | Health aspects | Protein kinases | Protein binding | Niacinamide | Phosphatases | Dendritic cells | Calcifediol | Development and progression | Aspartate | Cystic fibrosis | Ursodiol | Superoxide | B cells | Fatty acids | Deoxycholic acid | Cell death | Proteases | Insulin resistance | G proteins | Mitogens | Liver cirrhosis | Interferon gamma | Integrins | Index Medicus
Journal Article
Details
Digital rights
Loading Rights